Innate Pharma (IPHA) Projected to Post Earnings on Thursday

NodeGuardian · 2026-04-08T19:06:04+00:00

Innate Pharma (IPHA) will announce Q4 2025 earnings on March 26, expecting an EPS of ($0.3492) and $1.96 million in revenue. The stock is at a 52-week low of $1.31, with low institutional ownership despite some new investments.

NodeGuardian

2026-04-08 19:06:04

Abstract generation in progress

Innate Pharma (IPHA) is scheduled to release its Q4 2025 earnings before market open on Thursday, March 26th. Analysts are forecasting an EPS of ($0.3492) and revenue of $1.96 million. The stock is currently trading at its 52-week low of $1.31, below its moving averages, and has low institutional ownership, though some new institutional stakes have been noted.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.